Tapewire

NYSE · USD

IQV

IQVIA HOLDINGS INC.

Export transactions ↓
Tapewire entity
3058
SEC CIK
0001478242
Parsed reports
432

Last 12 months

Inside the activity.

0 purchase rows · 10 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202501
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202607
Aug 202601
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 09, 2024 Filed Feb 13, 2024 22:07 UTC
BOUSBIB ARIDirector · See Remarks
Tax withholdingCommon Stock 3,909 $218.20 $852,943.80
Disclosure

SEC source: 0001478242-24-000026 · wk-form4_1707862037.xml · nonDerivative · entry 1

BOUSBIB ARI · CIK 0001184180 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 788,918

Read SEC document
February 09, 2024 Filed Feb 13, 2024 22:08 UTC Tax withholdingCommon Stock 1,033 $218.20 $225,400.60
Disclosure

SEC source: 0001478242-24-000027 · wk-form4_1707862086.xml · nonDerivative · entry 1

Bruehlman Ronald E · CIK 0001604076 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,298

Read SEC document
February 07, 2024 Filed Feb 8, 2024 22:20 UTC GrantStock Appreciation Right · Derivative 1,726 $0.00 Strike: $214.34 $0.00
Disclosure

SEC source: 0001478242-24-000018 · wk-form4_1707430792.xml · derivative · entry 1

Cherofsky Keriann · CIK 0001940591 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,726

Underlying: Common Stock · 1,726 shares

Expires 2034-02-07

F1 · derivative.exercise_date: The stock appreciation right vests in three annual installments beginning on February 7, 2025.

Read SEC document
February 07, 2024 Filed Feb 8, 2024 22:19 UTC
STAUB W RICHARDSee Remarks
GrantStock Appreciation Right · Derivative 13,812 $0.00 Strike: $214.34 $0.00
Disclosure

SEC source: 0001478242-24-000017 · wk-form4_1707430756.xml · derivative · entry 3

STAUB W RICHARD · CIK 0001181162 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,812

Underlying: Common Stock · 13,812 shares

Expires 2034-02-07

F2 · derivative.exercise_date: The stock appreciation right vests in three annual installments beginning on February 7, 2025.

Read SEC document
February 07, 2024 Filed Feb 8, 2024 22:18 UTC GrantStock Appreciation Right · Derivative 20,719 $0.00 Strike: $214.34 $0.00
Disclosure

SEC source: 0001478242-24-000016 · wk-form4_1707430726.xml · derivative · entry 4

Bruehlman Ronald E · CIK 0001604076 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,719

Underlying: Common Stock · 20,719 shares

Expires 2034-02-07

F3 · derivative.exercise_date: The stock appreciation right vests in three annual installments beginning on February 7, 2025.

Read SEC document
February 07, 2024 Filed Feb 8, 2024 22:18 UTC
Knightly Kevin CSee Remarks
GrantStock Appreciation Right · Derivative 6,906 $0.00 Strike: $214.34 $0.00
Disclosure

SEC source: 0001478242-24-000015 · wk-form4_1707430689.xml · derivative · entry 3

Knightly Kevin C · CIK 0001350000 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,906

Underlying: Common Stock · 6,906 shares

Expires 2034-02-07

F2 · derivative.exercise_date: The stock appreciation right vests in three annual installments beginning on February 7, 2025.

Read SEC document
February 07, 2024 Filed Feb 8, 2024 22:17 UTC
BOUSBIB ARIDirector · See Remarks
GrantStock Appreciation Right · Derivative 72,517 $0.00 Strike: $214.34 $0.00
Disclosure

SEC source: 0001478242-24-000014 · wk-form4_1707430648.xml · derivative · entry 4

BOUSBIB ARI · CIK 0001184180 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,517

Underlying: Common Stock · 72,517 shares

Expires 2034-02-07

F3 · derivative.exercise_date: The stock appreciation right vests in three annual installments beginning on February 7, 2025.

Read SEC document
February 07, 2024 Filed Feb 8, 2024 22:17 UTC
Sherbet EricSee Remarks
GrantStock Appreciation Right · Derivative 9,496 $0.00 Strike: $214.34 $0.00
Disclosure

SEC source: 0001478242-24-000013 · wk-form4_1707430610.xml · derivative · entry 3

Sherbet Eric · CIK 0001679512 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,496

Underlying: Common Stock · 9,496 shares

Expires 2034-02-07

F2 · derivative.exercise_date: The stock appreciation right vests in three annual installments beginning on February 7, 2025.

Read SEC document
February 07, 2024 Filed May 9, 2024 21:07 UTC GrantDeferred Shares · Derivative 140 $214.34 $30,007.60
Disclosure

SEC source: 0001478242-24-000081 · wk-form4_1715288845.xml · derivative · entry 2

DANHAKL JOHN G · CIK 0001162644 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,723

Underlying: Common Stock · 140 shares

Expires not disclosed

F3 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F3 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F3 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
February 07, 2024 Filed May 9, 2024 21:09 UTC GrantDeferred Shares · Derivative 163 $214.34 $34,937.42
Disclosure

SEC source: 0001478242-24-000084 · wk-form4_1715288965.xml · derivative · entry 2

GOGGINS COLLEEN A · CIK 0001189008 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,481

Underlying: Common Stock · 163 shares

Expires not disclosed

F2 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F2 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F2 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
February 07, 2024 Filed May 9, 2024 21:09 UTC
Fasano JimDirector
GrantDeferred Shares · Derivative 163 $214.34 $34,937.42
Disclosure

SEC source: 0001478242-24-000083 · wk-form4_1715288930.xml · derivative · entry 1

Fasano Jim · CIK 0001633043 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 163

Underlying: Common Stock · 163 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
February 07, 2024 Filed May 9, 2024 21:08 UTC GrantDeferred Shares · Derivative 128 $214.34 $27,435.52
Disclosure

SEC source: 0001478242-24-000082 · wk-form4_1715288887.xml · derivative · entry 1

Wims Morris Leslie · CIK 0001908079 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,133

Underlying: Common Stock · 128 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
February 06, 2024 Filed Feb 8, 2024 22:19 UTC
STAUB W RICHARDSee Remarks
Tax withholdingCommon Stock 3,148 $215.41 $678,110.68
Disclosure

SEC source: 0001478242-24-000017 · wk-form4_1707430756.xml · nonDerivative · entry 2

STAUB W RICHARD · CIK 0001181162 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,613

Read SEC document
February 06, 2024 Filed Feb 8, 2024 22:19 UTC
STAUB W RICHARDSee Remarks
GrantCommon Stock 8,690 $0.00 $0.00
Disclosure

SEC source: 0001478242-24-000017 · wk-form4_1707430756.xml · nonDerivative · entry 1

STAUB W RICHARD · CIK 0001181162 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,761

F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 9, 2021. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 6, 2024.

Read SEC document
February 06, 2024 Filed Feb 8, 2024 22:18 UTC Tax withholdingCommon Stock 10,514 $215.41 $2,264,820.74
Disclosure

SEC source: 0001478242-24-000016 · wk-form4_1707430726.xml · nonDerivative · entry 2

Bruehlman Ronald E · CIK 0001604076 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,331

Read SEC document
February 06, 2024 Filed Feb 8, 2024 22:18 UTC GrantCommon Stock 24,141 $0.00 $0.00
Disclosure

SEC source: 0001478242-24-000016 · wk-form4_1707430726.xml · nonDerivative · entry 1

Bruehlman Ronald E · CIK 0001604076 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,845

F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 9, 2021. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 6, 2024.

Read SEC document
February 06, 2024 Filed Feb 8, 2024 22:18 UTC
Knightly Kevin CSee Remarks
Tax withholdingCommon Stock 2,688 $215.41 $579,022.08
Disclosure

SEC source: 0001478242-24-000015 · wk-form4_1707430689.xml · nonDerivative · entry 2

Knightly Kevin C · CIK 0001350000 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,526

Read SEC document
February 06, 2024 Filed Feb 8, 2024 22:18 UTC
Knightly Kevin CSee Remarks
GrantCommon Stock 7,241 $0.00 $0.00
Disclosure

SEC source: 0001478242-24-000015 · wk-form4_1707430689.xml · nonDerivative · entry 1

Knightly Kevin C · CIK 0001350000 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,214

F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 9, 2021. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 6, 2024.

Read SEC document
February 06, 2024 Filed Feb 8, 2024 22:17 UTC
BOUSBIB ARIDirector · See Remarks
Tax withholdingCommon Stock 43,677 $215.41 $9,408,462.57
Disclosure

SEC source: 0001478242-24-000014 · wk-form4_1707430648.xml · nonDerivative · entry 2

BOUSBIB ARI · CIK 0001184180 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 792,827

Read SEC document
February 06, 2024 Filed Feb 8, 2024 22:17 UTC
BOUSBIB ARIDirector · See Remarks
GrantCommon Stock 86,912 $0.00 $0.00
Disclosure

SEC source: 0001478242-24-000014 · wk-form4_1707430648.xml · nonDerivative · entry 1

BOUSBIB ARI · CIK 0001184180 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 836,504

F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 9, 2021. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 6, 2024.

Read SEC document
February 06, 2024 Filed Feb 8, 2024 22:17 UTC
Sherbet EricSee Remarks
Tax withholdingCommon Stock 2,372 $215.41 $510,952.52
Disclosure

SEC source: 0001478242-24-000013 · wk-form4_1707430610.xml · nonDerivative · entry 2

Sherbet Eric · CIK 0001679512 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,406

Read SEC document
February 06, 2024 Filed Feb 8, 2024 22:17 UTC
Sherbet EricSee Remarks
GrantCommon Stock 7,725 $0.00 $0.00
Disclosure

SEC source: 0001478242-24-000013 · wk-form4_1707430610.xml · nonDerivative · entry 1

Sherbet Eric · CIK 0001679512 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,778

F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 9, 2021. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 6, 2024.

Read SEC document
December 01, 2023 Filed Dec 5, 2023 22:01 UTC
Knightly Kevin CSee Remarks
Exercise / conversionStock Appreciation Right · Derivative 10,207 $59.90 Strike: $59.90 $611,399.30
Disclosure

SEC source: 0001478242-23-000103 · wk-form4_1701813671.xml · derivative · entry 8

Knightly Kevin C · CIK 0001350000 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,207 shares

Expires 2026-02-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 01, 2023 Filed Dec 5, 2023 22:01 UTC
Knightly Kevin CSee Remarks
Exercise / conversionStock Appreciation Right · Derivative 8,284 $65.16 Strike: $65.16 $539,785.44
Disclosure

SEC source: 0001478242-23-000103 · wk-form4_1701813671.xml · derivative · entry 7

Knightly Kevin C · CIK 0001350000 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,284 shares

Expires 2025-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 01, 2023 Filed Dec 5, 2023 22:01 UTC
Knightly Kevin CSee Remarks
Disposition to issuerCommon Stock 5,374 $214.23 $1,151,272.02
Disclosure

SEC source: 0001478242-23-000103 · wk-form4_1701813671.xml · nonDerivative · entry 6

Knightly Kevin C · CIK 0001350000 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,973

Read SEC document
December 01, 2023 Filed Dec 5, 2023 22:01 UTC
Knightly Kevin CSee Remarks
SaleCommon Stock 378 $215.29 $81,379.62
Disclosure

SEC source: 0001478242-23-000103 · wk-form4_1701813671.xml · nonDerivative · entry 5

Knightly Kevin C · CIK 0001350000 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,347

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $215.14 to $215.53, inclusive.

Read SEC document
December 01, 2023 Filed Dec 5, 2023 22:01 UTC
Knightly Kevin CSee Remarks
SaleCommon Stock 5,855 $214.32 $1,254,843.60
Disclosure

SEC source: 0001478242-23-000103 · wk-form4_1701813671.xml · nonDerivative · entry 4

Knightly Kevin C · CIK 0001350000 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,725

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $214.08 to $215.06, inclusive.

Read SEC document
December 01, 2023 Filed Dec 5, 2023 22:01 UTC
Knightly Kevin CSee Remarks
SaleCommon Stock 6,884 $213.72 $1,471,248.48
Disclosure

SEC source: 0001478242-23-000103 · wk-form4_1701813671.xml · nonDerivative · entry 3

Knightly Kevin C · CIK 0001350000 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,580

F1 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $213.08 to $214.07 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.

Read SEC document
December 01, 2023 Filed Dec 5, 2023 22:01 UTC
Knightly Kevin CSee Remarks
Exercise / conversionCommon Stock 10,207 $59.90 $611,399.30
Disclosure

SEC source: 0001478242-23-000103 · wk-form4_1701813671.xml · nonDerivative · entry 2

Knightly Kevin C · CIK 0001350000 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,464

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 01, 2023 Filed Dec 5, 2023 22:01 UTC
Knightly Kevin CSee Remarks
Exercise / conversionCommon Stock 8,284 $65.16 $539,785.44
Disclosure

SEC source: 0001478242-23-000103 · wk-form4_1701813671.xml · nonDerivative · entry 1

Knightly Kevin C · CIK 0001350000 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,257

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 09, 2023 Filed Feb 8, 2024 22:14 UTC GrantDeferred Shares · Derivative 156 $191.91 $29,937.96
Disclosure

SEC source: 0001478242-24-000011 · wk-form5_1707430480.xml · derivative · entry 4

DANHAKL JOHN G · CIK 0001162644 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,583

Underlying: Common Stock · 156 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
November 09, 2023 Filed Feb 8, 2024 22:15 UTC GrantDeferred Shares · Derivative 143 $191.91 $27,443.13
Disclosure

SEC source: 0001478242-24-000012 · wk-form5_1707430544.xml · derivative · entry 4

Wims Morris Leslie · CIK 0001908079 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,005

Underlying: Common Stock · 143 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
November 09, 2023 Filed Feb 8, 2024 22:13 UTC GrantDeferred Shares · Derivative 182 $191.91 $34,927.62
Disclosure

SEC source: 0001478242-24-000010 · wk-form5_1707430384.xml · derivative · entry 4

GOGGINS COLLEEN A · CIK 0001189008 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,318

Underlying: Common Stock · 182 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
September 19, 2023 Filed Sep 21, 2023 17:01 UTC Exercise / conversionStock Appreciation Right · Derivative 4,450 $0.00 Strike: $183.82 $0.00
Disclosure

SEC source: 0001478242-23-000091 · wk-form4_1695330080.xml · derivative · entry 11

Panagos Constantinos · CIK 0001917705 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,225

Underlying: Common Stock · 4,450 shares

Expires 2031-02-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 19, 2023 Filed Sep 21, 2023 17:01 UTC Exercise / conversionStock Appreciation Right · Derivative 11,202 $0.00 Strike: $161.70 $0.00
Disclosure

SEC source: 0001478242-23-000091 · wk-form4_1695330080.xml · derivative · entry 10

Panagos Constantinos · CIK 0001917705 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,202 shares

Expires 2030-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 19, 2023 Filed Sep 21, 2023 17:01 UTC Exercise / conversionStock Appreciation Right · Derivative 7,681 $0.00 Strike: $131.82 $0.00
Disclosure

SEC source: 0001478242-23-000091 · wk-form4_1695330080.xml · derivative · entry 9

Panagos Constantinos · CIK 0001917705 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,681 shares

Expires 2029-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 19, 2023 Filed Sep 21, 2023 17:01 UTC Exercise / conversionStock Appreciation Right · Derivative 2,853 $0.00 Strike: $95.23 $0.00
Disclosure

SEC source: 0001478242-23-000091 · wk-form4_1695330080.xml · derivative · entry 8

Panagos Constantinos · CIK 0001917705 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,853 shares

Expires 2028-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 19, 2023 Filed Sep 21, 2023 17:01 UTC Disposition to issuerCommon Stock 18,767 $208.56 $3,914,045.52
Disclosure

SEC source: 0001478242-23-000091 · wk-form4_1695330080.xml · nonDerivative · entry 7

Panagos Constantinos · CIK 0001917705 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,250

Read SEC document
September 19, 2023 Filed Sep 21, 2023 17:01 UTC SaleCommon Stock 7,419 $208.63 $1,547,825.97
Disclosure

SEC source: 0001478242-23-000091 · wk-form4_1695330080.xml · nonDerivative · entry 6

Panagos Constantinos · CIK 0001917705 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,017

F2 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $207.71 to $210.12 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
September 19, 2023 Filed Sep 21, 2023 17:01 UTC Exercise / conversionCommon Stock 4,450 $183.82 $817,999.00
Disclosure

SEC source: 0001478242-23-000091 · wk-form4_1695330080.xml · nonDerivative · entry 5

Panagos Constantinos · CIK 0001917705 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,436

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 19, 2023 Filed Sep 21, 2023 17:01 UTC Exercise / conversionCommon Stock 11,202 $161.70 $1,811,363.40
Disclosure

SEC source: 0001478242-23-000091 · wk-form4_1695330080.xml · nonDerivative · entry 4

Panagos Constantinos · CIK 0001917705 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,986

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 19, 2023 Filed Sep 21, 2023 17:01 UTC Exercise / conversionCommon Stock 7,681 $131.82 $1,012,509.42
Disclosure

SEC source: 0001478242-23-000091 · wk-form4_1695330080.xml · nonDerivative · entry 3

Panagos Constantinos · CIK 0001917705 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,784

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 19, 2023 Filed Sep 21, 2023 17:01 UTC Exercise / conversionCommon Stock 2,853 $95.23 $271,691.19
Disclosure

SEC source: 0001478242-23-000091 · wk-form4_1695330080.xml · nonDerivative · entry 2

Panagos Constantinos · CIK 0001917705 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,103

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 19, 2023 Filed Sep 21, 2023 17:01 UTC SaleCommon Stock 19,898 $208.69 $4,152,513.62
Disclosure

SEC source: 0001478242-23-000091 · wk-form4_1695330080.xml · nonDerivative · entry 1

Panagos Constantinos · CIK 0001917705 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,250

F1 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $207.78 to $210.33 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 03, 2023 Filed Aug 7, 2023 21:09 UTC Tax withholdingCommon Stock 2,588 $216.29 $559,758.52
Disclosure

SEC source: 0001478242-23-000089 · wk-form4_1691442559.xml · nonDerivative · entry 1

Bruehlman Ronald E · CIK 0001604076 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,704

Read SEC document
July 28, 2023 Filed Aug 1, 2023 21:00 UTC Tax withholdingCommon Stock 35 $226.15 $7,915.25
Disclosure

SEC source: 0001478242-23-000087 · wk-form4_1690923611.xml · nonDerivative · entry 1

Cherofsky Keriann · CIK 0001940591 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 864

Read SEC document
July 19, 2023 Filed Feb 8, 2024 22:14 UTC GrantDeferred Shares · Derivative 133 $225.46 $29,986.18
Disclosure

SEC source: 0001478242-24-000011 · wk-form5_1707430480.xml · derivative · entry 3

DANHAKL JOHN G · CIK 0001162644 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,427

Underlying: Common Stock · 133 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
July 19, 2023 Filed Feb 8, 2024 22:15 UTC GrantDeferred Shares · Derivative 122 $225.46 $27,506.12
Disclosure

SEC source: 0001478242-24-000012 · wk-form5_1707430544.xml · derivative · entry 3

Wims Morris Leslie · CIK 0001908079 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 862

Underlying: Common Stock · 122 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
July 19, 2023 Filed Feb 8, 2024 22:13 UTC GrantDeferred Shares · Derivative 155 $225.46 $34,946.30
Disclosure

SEC source: 0001478242-24-000010 · wk-form5_1707430384.xml · derivative · entry 3

GOGGINS COLLEEN A · CIK 0001189008 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,136

Underlying: Common Stock · 155 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
June 05, 2023 Filed Jun 7, 2023 21:31 UTC
Knightly Kevin CSee Remarks
SaleCommon Stock 5,820 $201.89 $1,174,999.80
Disclosure

SEC source: 0001478242-23-000079 · wk-form4_1686173474.xml · nonDerivative · entry 2

Knightly Kevin C · CIK 0001350000 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 0

F1 · ownership.nature: Held by Kevin Knightly Revocable Trust

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.